Increasing Prevalence Of Chronic Diseases To Drive The Growth Of Opioids Market Is Supporting Development Across The Opioids Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Market Value Of The Opioids Market Projected To Expand During 2026–2030?

The opioids market has experienced consistent expansion in its size over recent years. Projections indicate it will expand from $23.98 billion in 2025 to $24.63 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 2.7%. Historical market growth factors include the widespread occurrence of post-surgical pain, an increase in cancer cases, common opioid prescribing behaviors, restricted access to other pain relief options, and significant opioid consumption within hospitals.

The opioids market is projected to experience consistent expansion over the coming years. Its value is anticipated to reach $28.59 billion by 2030, driven by a compound annual growth rate (CAGR) of 3.8%. This projected growth during the forecast period stems from factors such as an expanding chronic pain demographic, advancements in developing safer opioid formulations, the broadening of palliative care services, clearer regulatory frameworks for controlled substances, and the escalating need for efficient pain management solutions among an aging populace. Key trends defining this period involve the evolution of precision-guided opioid therapies, the integration of digital prescription monitoring systems, a move towards formulations designed to deter abuse, the wider availability of long-acting and extended-release opioids, and their increasing application in managing oncology-related pain.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp

Which Strategic Drivers Are Supporting The Opioids Market Development?

The rising incidence of chronic diseases is anticipated to drive the expansion of the opioids market in the foreseeable future. Chronic conditions, also referred to as non-communicable diseases (NCDs), are long-lasting health issues that typically progress slowly and persist over an extended duration. These conditions frequently last for years or even a lifetime and generally do not resolve independently. The growing occurrence of chronic diseases is a significant determinant in the opioids market. As more individuals develop chronic conditions and experience persistent pain, there is a heightened demand for opioids. The use of opioids in chronic disease management is an intricate and evolving medical domain, known for its effective pain relief. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition involving elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Consequently, the expanding prevalence of chronic diseases is fueling the growth of the opioids market.

How Are Different Segment Groups Identified Within The Opioids Market?

The opioids market covered in this report is segmented –

1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types

2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist

3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain

4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies

5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment

Subsegments:

1) By Methadone: Methadone Tablets, Methadone Oral Solution

2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations

3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets

4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations

5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules

6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations

7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products

Which Trends Are Shaping The Opioids Market Landscape?

Major companies operating in the opioid market are concentrating on developing advanced drug solutions to enhance their competitive standing. The introduction of new medications is vital for treating diseases, improving healthcare, and expanding scientific knowledge. For instance, in May 2023, Braeburn Pharmaceuticals Inc., a US-based firm specializing in treatments for opioid addiction, announced that the US Food and Drug Administration authorized Brixadi (buprenorphine) extended-release injectable for subcutaneous use (beneath the skin) to treat direct to extreme opioid use disorder (OUD). This product is the first and only weekly and monthly subcutaneous infusion available for direct to serious OUD, and it marks the inaugural buprenorphine injectable to incorporate FluidCrystal Injection Depot Technology. Patients currently taking oral buprenorphine-containing medications can transition to equivalent dosages by adhering to the prescribed advice.

Which Companies Are Engaged In The Opioids Market Environment?

Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca Plc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals plc, Alkermes plc, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

Access The Complete Opioids Market Report:

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Which Area Represents The Largest Portion Of The Opioids Market?

North America was the largest region in the opioids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the opioids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Opioids Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp

Browse Through More Reports Similar to the Global Opioids Market 2026, By The Business Research Company

Opioids Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Morphine Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/morphine-drugs-global-market-report

Opioid Use Disorder Oud Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795